Targeting aberrant dendritic integration to treat cognitive comorbidities of epilepsy.

Brain · 2023 · PMC10232249 · PMID 36448426

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

did not reach statistical significanceP = 0.098so close (0.05 < p ≤ 0.1)

ANOVA revealed main effects on the alternation score of kainate treatment [sham-control versus epileptic: F (1,44) = 7.36, P = 0.0095], but the effects of ICA-121431 treatment did not reach statistical significance [ F (1,44) = 2.86, P = 0.098; interaction: F (1,44) = 0.82, P = 0.59; Fig. 7M , Bonferroni’s post-tests indicated with asterisks].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.